Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scelta Mycofriends is a Dutch biotechnology company specializing in the development and production of functional mushroom-based ingredients for the food, beverage, and nutraceutical industries. As a dedicated innovation arm of Scelta Mushrooms, the company utilizes proprietary UV-light technology and fermentation processes to create natural, clean-label solutions such as mushroom-derived Vitamin D2 and immune-supporting beta-glucans. Their products are designed to address global health challenges, including micronutrient deficiencies and the demand for natural sodium reduction through umami-rich extracts. Scelta Mycofriends operates at the intersection of mycology and life sciences, providing sustainable, plant-based ingredients that enhance the nutritional profile of consumer goods. The company is a key player in the "Mushroom Valley" region of the Netherlands, focusing on circular economy principles and evidence-based functional nutrition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scelta Mycofriends.